We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Beat the Market Like Zacks: NVIDIA, Boeing, Rockwell Medical in Focus
Read MoreHide Full Article
The three most widely followed indexes ended the week in the red, with the tech-heavy Nasdaq snapping a five-week winning streak. The Dow Jones Industrial Average fell for the second straight week, declining 0.2%, while the S&P 500 and the Nasdaq Composite shed 1.1% and 2.4%, respectively.
The week’s trading was marked by an over-bearing apprehension about strong data coming in from the labor market and how the Federal Reserve would interpret it. The general idea is that if economic data shows signs of strength at the current juncture, the Fed might revisit its recent dovish posture and re-embark on a path of accelerated interest rate hikes. The market’s sell-off indicated investors’ belief that such a course might induce a recession.
Also, the fear of an economic slowdown pushed treasury yields northside, thereby adversely impacting mega-cap growth and tech stocks. This led to the tech-heavy Nasdaq closing its first losing week of the year. All eyes are now set on the inflation numbers expected this week, and how the Fed reacts to it.
Regardless of market conditions, we, here at Zacks, provide investors with unbiased guidance on how to beat the market.
As usual, Zacks Research guided investors over the past three months with its time-tested methodologies. Given the prevailing market uncertainty, you may want to look at our feats to prepare better for your next action.
Here are some of our key achievements:
Rockwell Medical, Compagnie Financière Richemont Surge Following Zacks Rank Upgrade
Shares of Rockwell Medical, Inc. (RMTI - Free Report) have surged 62.9% since it was upgraded to a Zacks Rank #2 (Buy) on November 16.
Another stock, Compagnie Financière Richemont SA (CFRUY - Free Report) , which was also upgraded to a Zacks Rank #2 on November 29, has returned 23.7% since then.
Zacks Rank, our short-term rating system, has earnings estimate revisions at its core. Empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
This stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 to Zacks Rank #5 (Strong Sell), has an impressive externally audited track record, with Zacks Rank #1 stocks generating an average annual return of +24.8% since 1988.You can see the complete list of today’s Zacks Rank #1 stocks here >>>
Zacks Recommendation Upgrade Drives Inter Parfums and Commercial Metals Higher
Shares of Inter Parfums, Inc. (IPAR - Free Report) and Commercial Metals Company (CMC - Free Report) have soared 24% and 21.1% since their Zacks Recommendation was upgraded to Outperform on November 23 and November 14, respectively.
While the Zacks Rank is our short-term rating system that is most effective over the one- to three-month holding horizon, the Zacks Recommendation aims to predict performance over the next 6 to 12 months. However, just like the Zacks Rank, the foundation for the Zacks Recommendation is trends in earnings estimate revisions.
The Zacks Recommendation classifies stocks into three groups — Outperform, Neutral and Underperform. While these recommendations are determined quantitatively, our analysts have the flexibility to override them for the 1100+ stocks they closely follow based on their better judgment of factors such as valuation, industry conditions and management effectiveness than the quantitative model.
To access our research reports with Zacks Recommendations for the 1100+ stocks we cover, click here>>>
Zacks Focus List Model Portfolio NVIDIA, Boeing Soar
Shares of NVIDIA Corporation (NVDA - Free Report) , which belongs to the Zacks Focus List, have risen 38% over the past 12 weeks. The stock was added to the Focus List on May 20, 2019. Another Focus-List holding, The Boeing Company (BA - Free Report) , which was added to the portfolio on March 23, 2020, has returned 22.4% over the past 12 weeks.
The Zacks Focus List is a model portfolio of 50 hand-picked stocks that possess the right fundamental ingredients to outperform the market over the next 12 months. These 50 stocks are picked from a long list of stocks with the highest Zacks Rank.
Since its inception on February 1, 1996, the Focus List portfolio has delivered an annualized return of +12.9%.
Unlock all of our powerful research, tools and analysis, including the Focus List, Zacks #1 Rank List, Equity Research Reports, Zacks Earnings ESP Filter, Premium Screener and more, as part of Zacks Premium. Gain full access now >>
Zacks ECAP Stocks Novo Nordisk and Fiserv Rapidly Advance
Novo Nordisk A/S (NVO - Free Report) , a component of our Earnings Certain Admiral Portfolio (ECAP), jumped 23% over the past 12 weeks. Fiserv, Inc. followed Novo Nordisk with 15.8% returns.
ECAP is a model portfolio of 30 concentrated, ultra-defensive, long-term Buy and Hold stocks.
With little to no turnover and annual rebalance periodicity, the ECAP seeks to minimize capital loss by holding shares of companies whose earnings streams exhibit a proven 20+ year track record of surviving recessionary periods with minimal impact on aggregate earnings growth relative to the overall S&P 500.
The ECAP and many other model portfolios are available as part of Zacks Advisor Tools, a cloud-based solution to access Zacks award-winning stock, mutual fund and ETF research. Click here to schedule a demo.
Starbucks Corporation (SBUX - Free Report) , which is part of our Earnings Certain Dividend Portfolio (ECDP), has returned 9.3% over the past 12 weeks. Another ECDP stock, C.H. Robinson Worldwide, Inc. (CHRW - Free Report) , has climbed 6.2% over the same time frame. Of course, the inclination of investors toward quality dividend stocks to secure an income stream amid the heightened market volatility contributed to this performance.
With an extremely low Beta and a history of minimum earnings variability over the last 20+ years, this 25-stock portfolio helps significantly mitigate risk. The ECDP has consistently outperformed the S&P 500 Dividend Aristocrats ETF (NOBL - Free Report) .
Image: Bigstock
Beat the Market Like Zacks: NVIDIA, Boeing, Rockwell Medical in Focus
The three most widely followed indexes ended the week in the red, with the tech-heavy Nasdaq snapping a five-week winning streak. The Dow Jones Industrial Average fell for the second straight week, declining 0.2%, while the S&P 500 and the Nasdaq Composite shed 1.1% and 2.4%, respectively.
The week’s trading was marked by an over-bearing apprehension about strong data coming in from the labor market and how the Federal Reserve would interpret it. The general idea is that if economic data shows signs of strength at the current juncture, the Fed might revisit its recent dovish posture and re-embark on a path of accelerated interest rate hikes. The market’s sell-off indicated investors’ belief that such a course might induce a recession.
Also, the fear of an economic slowdown pushed treasury yields northside, thereby adversely impacting mega-cap growth and tech stocks. This led to the tech-heavy Nasdaq closing its first losing week of the year. All eyes are now set on the inflation numbers expected this week, and how the Fed reacts to it.
Regardless of market conditions, we, here at Zacks, provide investors with unbiased guidance on how to beat the market.
As usual, Zacks Research guided investors over the past three months with its time-tested methodologies. Given the prevailing market uncertainty, you may want to look at our feats to prepare better for your next action.
Here are some of our key achievements:
Rockwell Medical, Compagnie Financière Richemont Surge Following Zacks Rank Upgrade
Shares of Rockwell Medical, Inc. (RMTI - Free Report) have surged 62.9% since it was upgraded to a Zacks Rank #2 (Buy) on November 16.
Another stock, Compagnie Financière Richemont SA (CFRUY - Free Report) , which was also upgraded to a Zacks Rank #2 on November 29, has returned 23.7% since then.
Zacks Rank, our short-term rating system, has earnings estimate revisions at its core. Empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
This stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 to Zacks Rank #5 (Strong Sell), has an impressive externally audited track record, with Zacks Rank #1 stocks generating an average annual return of +24.8% since 1988.You can see the complete list of today’s Zacks Rank #1 stocks here >>>
Check Rockwell Medical's historical EPS and Sales here>>>
Check Compagnie Financière Richemont's historical EPS and Sales here>>>
Image Source: Zacks Investment Research
Zacks Recommendation Upgrade Drives Inter Parfums and Commercial Metals Higher
Shares of Inter Parfums, Inc. (IPAR - Free Report) and Commercial Metals Company (CMC - Free Report) have soared 24% and 21.1% since their Zacks Recommendation was upgraded to Outperform on November 23 and November 14, respectively.
While the Zacks Rank is our short-term rating system that is most effective over the one- to three-month holding horizon, the Zacks Recommendation aims to predict performance over the next 6 to 12 months. However, just like the Zacks Rank, the foundation for the Zacks Recommendation is trends in earnings estimate revisions.
The Zacks Recommendation classifies stocks into three groups — Outperform, Neutral and Underperform. While these recommendations are determined quantitatively, our analysts have the flexibility to override them for the 1100+ stocks they closely follow based on their better judgment of factors such as valuation, industry conditions and management effectiveness than the quantitative model.
To access our research reports with Zacks Recommendations for the 1100+ stocks we cover, click here>>>
Zacks Focus List Model Portfolio NVIDIA, Boeing Soar
Shares of NVIDIA Corporation (NVDA - Free Report) , which belongs to the Zacks Focus List, have risen 38% over the past 12 weeks. The stock was added to the Focus List on May 20, 2019. Another Focus-List holding, The Boeing Company (BA - Free Report) , which was added to the portfolio on March 23, 2020, has returned 22.4% over the past 12 weeks.
The Zacks Focus List is a model portfolio of 50 hand-picked stocks that possess the right fundamental ingredients to outperform the market over the next 12 months. These 50 stocks are picked from a long list of stocks with the highest Zacks Rank.
Since its inception on February 1, 1996, the Focus List portfolio has delivered an annualized return of +12.9%.
Unlock all of our powerful research, tools and analysis, including the Focus List, Zacks #1 Rank List, Equity Research Reports, Zacks Earnings ESP Filter, Premium Screener and more, as part of Zacks Premium. Gain full access now >>
Zacks ECAP Stocks Novo Nordisk and Fiserv Rapidly Advance
Novo Nordisk A/S (NVO - Free Report) , a component of our Earnings Certain Admiral Portfolio (ECAP), jumped 23% over the past 12 weeks. Fiserv, Inc. followed Novo Nordisk with 15.8% returns.
ECAP is a model portfolio of 30 concentrated, ultra-defensive, long-term Buy and Hold stocks.
With little to no turnover and annual rebalance periodicity, the ECAP seeks to minimize capital loss by holding shares of companies whose earnings streams exhibit a proven 20+ year track record of surviving recessionary periods with minimal impact on aggregate earnings growth relative to the overall S&P 500.
The ECAP and many other model portfolios are available as part of Zacks Advisor Tools, a cloud-based solution to access Zacks award-winning stock, mutual fund and ETF research. Click here to schedule a demo.
Zacks ECDP Stocks Starbucks, C.H. Robinson Outperform Peers
Starbucks Corporation (SBUX - Free Report) , which is part of our Earnings Certain Dividend Portfolio (ECDP), has returned 9.3% over the past 12 weeks. Another ECDP stock, C.H. Robinson Worldwide, Inc. (CHRW - Free Report) , has climbed 6.2% over the same time frame. Of course, the inclination of investors toward quality dividend stocks to secure an income stream amid the heightened market volatility contributed to this performance.
Check Starbucks’ dividend history here>>>
Check C.H. Robinson’s dividend history here>>>
With an extremely low Beta and a history of minimum earnings variability over the last 20+ years, this 25-stock portfolio helps significantly mitigate risk. The ECDP has consistently outperformed the S&P 500 Dividend Aristocrats ETF (NOBL - Free Report) .
Click here to access this portfolio on Zacks Advisor Tools.